Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

被引:29
|
作者
Phung Anh Nguyen [1 ]
Islam, Mohaimenul [1 ,2 ]
Galvin, Cooper J. [1 ]
Chang, Chih-Cheng [3 ,4 ]
An, Soo Yeon [5 ]
Yang, Hsuan-Chia [4 ]
Huang, Chih-Wei [1 ]
Li, Yu-Chuan [1 ,4 ,6 ]
Iqbal, Usman [1 ,7 ]
机构
[1] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei 235, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan
[5] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon 35015, South Korea
[6] Wan Fang Hosp, Dept Dermatol, Taipei 116, Taiwan
[7] Taipei Med Univ, Coll Publ Hlth, Global Hlth & Dev Dept, Global Hlth & Hlth Secur, Taipei 11031, Taiwan
关键词
clinical study; epidemiology; gastrointestinal diseases; pneumonia; proton pump inhibitors; OBSTRUCTIVE PULMONARY-DISEASE; STRESS-ULCER; ADULTS; HOSPITALIZATION; PREVENTION; MANAGEMENT; DIAGNOSIS; THERAPY;
D O I
10.1093/intqhc/mzaa041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Proton pump inhibitors (PPIs), one of the most widely used medications, are commonly used to suppress several acid-related upper gastrointestinal disorders. Acid-suppressing medication use could be associated with increased risk of community-acquired pneumonia (CAP), although the results of clinical studies have been conflicting. Data sources: A comprehensive search of MEDLINE, EMBASE and Cochrane library and Database of Systematic Reviews from the earliest available online year of indexing up to October 2018. Study selection: We performed a systematic review and meta-analysis of observational studies to evaluate the risk of PPI use on CAP outcomes. Data extraction: Included study location, design, population, the prevalence of CAP, comparison group and other confounders. We calculated pooled odds ratio (OR) using a random-effects meta-analysis. Results of data synthesis: Of the 2577 studies screening, 11 papers were included in the systematic review and 7 studies with 65 590 CAP cases were included in the random-effects meta-analysis. In current PPI users, pooled OR for CAP was 1.86 (95% confidence interval (CI), 1.30-2.66), and in the case of recent users, OR for CAP was 1.66 (95% CI, 1.22-2.25). In the subgroup analysis of CAP, significance association is also observed in both high-dose and low-dose PPI therapy. When stratified by duration of exposure, 3-6 months PPIs users group was associated with increased risk of developing CAP (OR, 2.05; 95% CI, 1.22-3.45). There was a statistically significant association between the PPI users and the rate of hospitalization (OR, 2.59; 95% CI, 1.83-3.66). Conclusion: We found possible evidence linking PPI use to an increased risk of CAP. More randomized controlled studies are warranted to clarify an understanding of the association between PPI use and risk of CAP because observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [22] Antihypertensive medications and risk of community-acquired pneumonia
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    O'Meara, Ellen S.
    Gautam, Shiva
    JOURNAL OF HYPERTENSION, 2010, 28 (02) : 401 - 405
  • [23] Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia
    Violi, Francesco
    Cangemi, Roberto
    Falcone, Marco
    Taliani, Gloria
    Pieralli, Filippo
    Vannucchi, Vieri
    Nozzoli, Carlo
    Venditti, Mario
    Chirinos, Julio A.
    Corrales-Medina, Vicente F.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1486 - 1493
  • [24] Community-acquired pneumonia
    Falguera, M.
    Ramirez, M. F.
    REVISTA CLINICA ESPANOLA, 2015, 215 (08): : 458 - 467
  • [25] Accuracy of Signs and Symptoms for the Diagnosis of Community-acquired Pneumonia: A Meta-analysis
    Ebell, Mark H.
    Chupp, Hulme
    Cai, Xinyan
    Bentivegna, Michelle
    Kearney, Maggie
    ACADEMIC EMERGENCY MEDICINE, 2020, 27 (07) : 542 - 553
  • [26] Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
    Burk, Michael
    El-Kersh, Karim
    Saad, Mohamed
    Wiemken, Timothy
    Ramirez, Julio
    Cavallazzi, Rodrigo
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (140) : 178 - 188
  • [27] Corticosteroids in sepsis and community-acquired pneumonia
    Guzzardella, Amedeo
    Motos, Ana
    Vallverdu, Jordi
    Torres, Antoni
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2023, 118 (SUPPL 2) : 86 - 92
  • [28] Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
    Baskaran, Vadsala
    Quammie, Shauntelle
    Lawrence, Hannah
    Ashton, Deborah
    Lim, Wei Shen
    Mckeever, Tricia
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Proton-pump inhibitors and risk of fractures: an update meta-analysis
    Zhou, B.
    Huang, Y.
    Li, H.
    Sun, W.
    Liu, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 339 - 347
  • [30] Pharmacotherapy and the risk for community-acquired pneumonia
    Gau, Jen-Tzer
    Acharya, Utkarsh
    Khan, Salman
    Heh, Victor
    Mody, Lona
    Kao, Tzu-Cheg
    BMC GERIATRICS, 2010, 10